§ BIOTECHNOLOGY
USD · Biotechnology

BCRX

BIOCRYST PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 0.60
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
198 increased/new, 91 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E8.5P/B13.88
EPS (TTM)1.20
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.22.7M0.0%+7%
RA CAPITAL MANAGEMENT, L.P.15.8M1.6%±0%
DEERFIELD MANAGEMENT COMPANY, L.P.15.0M1.7%+5%
State Street12.2M0.0%+10%
VANGUARD PORTFOLIO MANAGEMENT LLC11.2Mn/an/a
VANGUARD CAPITAL MANAGEMENT LLC11.1Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for BCRX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER87.6% · 0 holders
OTHER7.3% · 208 holders
QUALITY / COMPOUNDER1.6% · 18 holders
PASSIVE / INDEX1.6% · 10 holders
DEALER / BANK1.5% · 28 holders
TACTICAL / MACRO0.1% · 6 holders
INCOME / DEFENSIVE0.1% · 18 holders
SYSTEMATIC / QUANT0.1% · 11 holders
GROWTH / MOMENTUM0.0% · 1 holder
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for BCRX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention BCRX yet.